Silver activates calcium signals in rat basophilic leukemia-2H3 mast cells by a mechanism that differs from the FcεRI-activated response

Journal of Immunology

Volumn 169, Issue 7, 2002, Pages 3954-3962

  Suzuki, Yoshihiro ^a   Yoshimaru, Tetsuro ^a   Matsui, Takashi ^a   Ra, Chisei ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALCIUM; INTERLEUKIN 4; LEUKOTRIENE C4; MITOGEN ACTIVATED PROTEIN KINASE; SILVER; THAPSIGARGIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL ACTIVATION; CONCENTRATION (PARAMETERS); CROSS LINKING; CYTOKINE PRODUCTION; HISTAMINE RELEASE; IMMUNOPRECIPITATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0036784650     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.7.3954     Document Type: Article

References (43)

1. Eneström, S., and P. Hultman. 1991. Does amalgam affects the immune system: a controversial issue. Int. Arch. Allergy Immunol. 106:180.
2. Oliveira, D. B. G., K. M. Gillespie, K. Wolfreys, P. W. Mathieson, F. Qasim, and J. W. Coleman. 1995. Compounds that induce autoimmunity in the brown Norway rat sensitize mast cells for mediator release and interleukin-4 expression. Eur. J. Immunol. 25:2259.
3. Wolfreys, K., and D. B. G. Oliveira. 1997. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur. J. Immunol. 27:297.
4. Dastych, J., A. Walczak-Drzewiecka, J. Wyczolkowska, and D. D. Metcalfe. 1993. Murine mast cells exposed to mercuric chloride release granule-associated N-acetyl-β-D-hexosaminidase and secrete IL-4 and TNF-α. J. Allergy Clin. Immunol. 103:1108.
5. Röger, J., D. Zillikens, A. A. Hartmann, G. Burg, and E. Gleichmann. 1992. Systemic autoimmune disease in a patient with long-standing exposure to mercury. Eur. J. Dermatol. 2:168.
6. Sapin, C., E. Druet, and P. Druet. 1977. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin. Exp. Immunol. 28:173.
7. Pusey, C. D., C. Bowman, A. Morgan, A. P. Weetman, B. Hartley, and C. M. Lockwood. 1990. Kinetics and pathogenecity of autoantibodies induced by mercuric chloride in the Brown Norway rat. Clin. Exp. Immunol. 81:76.
8. Esnault, V. L. M., P. W. Mathieson, S. Thiru, D. B. G, Oliveira, and C. M. Lockwood. 1992. Autoantibodies to myeloperoxidase in Brown Norway rats treated with mercuric chloride. Lab. Invest. 67:114.
9. Mathieson, P. W., S. Thiru, and D. B. G. Oliveira. 1992. Mercuric chloridetreated Brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab. Invest. 67:121.
10. Kiely, P. D. W., S. Thiru, and D. B. G. Oliveira. 1995. Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab. Invest. 73:284.
11. 2 in the rat. J. Immunol. 126:699.
12. Roman-Franco, A. A., M. Turiello, B. Albini, B. E. Osi, F. Milgrom, and G. A. Andres. 1878. Antibasement membrane antibodies and antigen-antibody complexes in rabbits injected with mercuric chloride. Clin. Immunol. Immunopathol. 9:464.
13. Enestörm, S., and P. Hultman. 1984. Immune-mediated glomerulonephritis induced by mercuric chloride in mice. Experientia 40:1234.
14. Goter-Robinson, C. J., A. Abraham, and T. Balazs. 1984. Induction of antinuclear antibodies by mercuric chloride in mice. Clin. Exp. Immunol. 58:300.
15. Hultman, P., S. Eneström, S. J. Turley, and K. M. Pollard. 1994. Selective induction of antifibrillarin autoantibody by silver nitrate. Clin. Exp. Immunol. 96: 285.
16. Jansson, G., and M. Harms-Rigdahl. 1993. Stimulating effects of mercuric and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic. Res. Commun. 18:87.
17. + induces cell degranulation and mediator release. Biochem. Biophys. Res. Commun. 283:707.
18. FAK by the aggregation of high affinity immunoglobulin E receptor requires cell adherence. J, Biol. Chem. 268:6851.
19. Yoshimaru, T., Y. Suzuki, T. Matsui, K. Yamashita, T. Ochiai, M. Yamaki, and K. Shimizu. 2002. Blockade of superoxide generation prevents high affinity immunoglobulin E receptor-mediated release of allergic mediators by rat mast cell line and human basophils. Clin. Exp. Allergy 32:612.
20. 2+ entry: role of actin cytoskeleton. J. Biol. Chem. 276:5134.
21. syk in high affinity IgE receptor signaling: identification as a component of pp72 and association with the receptor γ-chain after receptor aggregation. J. Biol. Chem. 268:23318.
22. Barsumian, E. L., C. Isersky, M. G. Petrino, and R. P. Siraganian. 1981. IgE-induced histamine release from rat basophilic leukemia cell lines: isolation of releasing and nonreleasing clones. Eur. J. Immunol. 11:317.
23. Fukamachi, H., M. Takei, and T. Kawakami. 1993. Activation of multiple protein kinases including a MAP kinase upon FcεRI cross-linking. Int. Arch. Allergy Immunol. 102:15.
24. 2 pathway in rat mast cell line. J. Immunol. 154:5391.
25. Santini, F., and M. A. Beaven. 1993. Tyrosine phosphorylation of a mitogenactivated protein kinase-like protein occurs at a late step in exocytosis. J. Biol. Chem. 268:22716.
26. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
27. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
28. Turner, H., and J. P. Kinet. 1999. Signaling through the high-affinity IgE receptor FcεRI. Nature 402:B24.
29. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:931.
30. Putney, J. W., Jr., and G. S. Bird. 1993. The signal for capacitative calcium entry. Cell 75:199.
31. Ohuchi, K., T. Sugawara, M. Watanabe, N. Hirasawa, S. Turufuji, H. Fujiki, S. B. Christensen, and T. Sugimura. 1988. Analysis of the stimulate effects of thapsigargin, a non-TPA-type tumour promoter, on arachidonic acid metabolism in rat peritoneal macrophages. Br. J. Pharmacol. 94:917.
32. Takemura, H., O. Thastrup, and J. W. Putney, Jr. 1990. Calcium efflux across the plasma membrane of rat parotid acinar cells is unaffected by receptor activated or by the microsomal calcium ATPase inhibitor, thapsigargin. Cell Calcium 11:11.
33. Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, and L. E. Samelson. 2000. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12:525.
34. Rivera, J., R. Arudchundran, C. Gonzalez-Espinosa, T. S. Manetz, and S. Xirasagar. 2001. A perspective: regulation of IgE receptor-mediated mast cell responses by a LAT-organized plasma membrane-localized signaling complex. Int. Arch. Allergy Immunol. 124:137.
35. 2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J. Immunol. 158:2350.
36. Kawakami, Y., J. Kitaura, A. B. Satterthwaite, R. M. Kato, K, Asai, S. E. Hartman, M. Maeda-Yamamoto, C, A. Lowell, D. J. Rawlings, O. N. Witte, and T. Kawakami. 2000. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165:1210.
37. Parekh, A. B., and R. Penner. 1997. Store depletion and calcium influx. Physiol. Rev. 77:901.
38. 2+ store. Biochem. J. 265:675.
39. Putney, J. W., Jr. 1991. The capacitative model for receptor-activated calcium entry. Adv. Pharmacol. 22:251.
40. Geahlen, R. L., and J. L. McLaughlin. 1989, Piceatannol (3,4,3′,5′-tetrahydroxytrans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun. 165:241.
41. Oliver, J. M., D. L. Burg, B. S. Wilson, J. L. McLaughlin, and R. L. Geahlen. 1994. Inhibition of mast cell FcεRI-mediated signaling and effector function by the Syk selective inhibitor, piceatannol. J. Biol. Chem. 269:29697.
42. Amoui, M., P. Dráber, and L. Dráberová. 1997. Src family-selective tyrosine kinase inhibitor, PPI inhibits both FcεRI- and Thy-1-mediated activation of rat basophilic leukemia cells. Eur. J. Immunol. 27:1881.
43. Hanke, J. H., J. P. Gardner, R. L. Dow, P. S. Changelian, W. H. Brisserte, E. J. Weringer, B. A. Pollok, and P. A. Connelly. 1996. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck- and Fyndependent T cell activation. J. Biol. Chem. 271:695.